×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [23]
山东大学 [19]
深圳先进技术研究院 [17]
中国医学科学院 北... [17]
兰州大学 [16]
中国农业科学院 [16]
更多...
内容类型
期刊论文 [135]
会议论文 [27]
其他 [1]
发表日期
2021 [1]
2019 [25]
2018 [18]
2017 [13]
2016 [20]
2015 [16]
更多...
学科主题
农作物 [4]
农学(农艺学) [2]
Biological... [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共163条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Spatial and Temporal Changes in Vegetation in the Ruoergai Region, China
期刊论文
FORESTS, 2021, 卷号: 12, 期号: 1, 页码: 17
作者:
Guo, Yahui
;
Zeng, Jing
;
Wu, Wenxiang
;
Hu, Shunqiang
;
Liu, Guangxu
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2021/03/15
NDVI
vegetation
Savitzky–
Golay filtering
spatial and temporal analysis
Ruoergai area
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china
期刊论文
JOURNAL OF HEPATOLOGY, 2019, 卷号: 70
作者:
Gong, Guozhong
;
Wei, Lai
;
Xu, Xiaoyuan
;
Guan, Yujuan
;
Zheng, Sujun
收藏
  |  
浏览/下载:56/0
  |  
提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china
会议论文
作者:
Wei, Lai
;
Xu, Xiaoyuan
;
Guan, Yujuan
;
Zheng, Sujun
;
Sheng, Ji-Fang
收藏
  |  
浏览/下载:45/0
  |  
提交时间:2019/12/05
Construction and evaluation of introgression lines and fine mapping of ehd8 from Jinghong common wild rice (Oryza rufipogon)
期刊论文
PLANT BREEDING, 2019, 卷号: 138, 期号: 2
作者:
Sun, Dayun
;
Wang, Wenxiang
;
Xin, Xiaoyun
;
Cao, Liming
;
Sun, Xuejun
收藏
  |  
浏览/下载:37/0
  |  
提交时间:2019/12/05
common wild rice
heading date
introgression lines
Oryza rufipogon
photoperiod
simple sequence repeat
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial
期刊论文
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 卷号: 52, 期号: 1
作者:
Yuan, Jinyi
;
Mo, Biwen
;
Ma, Zhuang
;
Lv, Yuan
;
Cheng, Shih-Lung
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2019/12/05
Clinical outcome
Community-acquired pneumonia
Levofloxacin
Nemonoxacin
Randomized controlled trial
Safety
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial
期刊论文
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 卷号: 52, 期号: 1
作者:
Perng, Wann Cherng
;
Chuang, Yin Ching
;
Wu, Xiaoju
;
Xiao, Yi
;
Shen, Ce
收藏
  |  
浏览/下载:49/0
  |  
提交时间:2019/12/05
Clinical outcome
Community-acquired pneumonia
Levofloxacin
Nemonoxacin
Randomized controlled trial
Safety
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL
会议论文
作者:
Wei, Lai
;
Xu, Xiaoyuan
;
Zheng, Sujun
;
Guan, Yujuan
;
Sheng, Jifang
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2019/12/05
Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial
期刊论文
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2019, 卷号: 52, 期号: 1
作者:
Yuan, Jinyi
;
Mo, Biwen
;
Ma, Zhuang
;
Lv, Yuan
;
Cheng, Shih-Lung
收藏
  |  
浏览/下载:50/0
  |  
提交时间:2019/12/05
Clinical outcome
Community-acquired pneumonia
Levofloxacin
Nemonoxacin
Randomized controlled trial
Safety
Rhodiola crenulata attenuates apoptosis and mitochondrial energy metabolism disorder in rats with hypobaric hypoxia-induced brain injury by regulating the HIF-1 alpha/microRNA 210/ISCU1/2(COX10) signaling pathway
期刊论文
2019, 卷号: 241
作者:
Wang, Xiaobo[1,2]
;
Hou, Ya[1,2]
;
Li, Qiuyue[3]
;
Li, Xuanhao[1,3]
;
Wang, Wenxiang[1]
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2019/12/06
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china
会议论文
作者:
Wei, Lai
;
Xu, Xiaoyuan
;
Guan, Yujuan
;
Zheng, Sujun
;
Sheng, Ji-Fang
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2019/12/05
©版权所有 ©2017 CSpace - Powered by
CSpace